水産養殖用ワクチン市場レポート：2030年までの動向、予測、競合分析

養殖用ワクチンの動向と予測

世界の水産養殖用ワクチン市場は、2024年から2030年までのCAGRが7.6％で、2030年までに推定7億米ドルに達すると予想されます。この市場の主な促進要因は、水産動物由来の食品需要の増加、水産養殖セクターにおける感染症の顕著な増加、水産養殖生産の拡大です。世界の水産養殖用ワクチン市場の将来は、不活化ワクチン市場とDNAワクチン市場にビジネスチャンスがあり、有望視されています。

水産養殖用ワクチン市場洞察

Lucintelは、腫症、ビブリオ症、冷水性ビブリオ症、冬爛症、IPN、サケ伝染性貧血症（ISA）など、多くの病気の予防措置として水生動物に広く使用されているため、注射剤がより大きなセグメントであり続けると予測しています。

アジア太平洋はこの地域最大の水産養殖産業の1つであるため、予測期間中に最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答している：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の水産養殖用ワクチン市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018～2030年の市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の水産養殖用ワクチン市場動向（2018～2023）と予測（2024～2030）
• 製品別の世界の水産養殖用ワクチン市場
  • 不活化ワクチン
  • DNAワクチン
• 投与経路別の世界の水産養殖用ワクチン市場
  • 注射
  • 経口

第4章 2018～2030年の地域別の市場動向と予測分析

• 地域別の世界の水産養殖用ワクチン市場
• 北米の水産養殖用ワクチン市場
• 欧州の水産養殖用ワクチン市場
• アジア太平洋の水産養殖用ワクチン市場
• その他地域の水産養殖用ワクチン市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 製品別の世界の水産養殖用ワクチン市場の成長機会
  • 投与経路別の世界の水産養殖用ワクチン市場の成長機会
  • 地域別の世界の水産養殖用ワクチン市場の成長機会
• 世界の水産養殖用ワクチン市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の水産養殖用ワクチン市場の能力拡大
  • 世界の水産養殖用ワクチン市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• GlaxoSmithKline
• Merck
• Pfizer
• Sanofi
• CSL
• Emergent BioSolutions
• Johnson & Johnson
• AstraZeneca
• Serum Institute of India
• Bavarian Nordic

Aquaculture Vaccine Trends and Forecast

The future of the global aquaculture vaccine market looks promising with opportunities in the inactivated and dna markets. The global aquaculture vaccine market is expected to reach an estimated $0.7 billion by 2030 with a CAGR of 7.6% from 2024 to 2030. The major drivers for this market are increasing demand for food products derived from aquatic animals, notable rise in infectious diseases within the aquaculture sector, and expansion of aquaculture production.

A more than 150-page report is developed to help in your business decisions.

Aquaculture Vaccine by Segment

The study includes a forecast for the global aquaculture vaccine by product, route of administration, and region.

Aquaculture Vaccine Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Inactivated Vaccines
• DNA Vaccines

Aquaculture Vaccine Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

• Injected
• Oral

Aquaculture Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Aquaculture Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies aquaculture vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the aquaculture vaccine companies profiled in this report include-

• GlaxoSmithKline
• Merck
• Pfizer
• Sanofi
• CSL
• Emergent BioSolutions
• Johnson & Johnson
• AstraZeneca
• Serum Institute of India
• Bavarian Nordic

Aquaculture Vaccine Market Insights

Lucintel forecasts that injected will remain the larger segment due to its widespread use in aquatic animals as a preventative measure against a number of illnesses, including as furunculosis, vibriosis, cold-water vibriosis, winter sore, IPN, and infectious salmon anemia (ISA).

APAC is expected to witness highest growth over the forecast period due to the presence of one of the region's largest aquaculture industries in the region.

Features of the Global Aquaculture Vaccine Market

Market Size Estimates: Aquaculture vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Aquaculture vaccine market size by product, route of administration, and region in terms of value ($B).

Regional Analysis: Aquaculture vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, route of administrations, and regions for the aquaculture vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the aquaculture vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the aquaculture vaccine market size?

Answer: The global aquaculture vaccine market is expected to reach an estimated $0.7 billion by 2030.

Q.2 What is the growth forecast for aquaculture vaccine market?

Answer: The global aquaculture vaccine market is expected to grow with a CAGR of 7.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the aquaculture vaccine market?

Answer: The major drivers for this market are increasing demand for food products derived from aquatic animals, notable rise in infectious diseases within the aquaculture sector, and expansion of aquaculture production.

Q4. What are the major segments for aquaculture vaccine market?

Answer: The future of the aquaculture vaccine market looks promising with opportunities in the inactivated and dna markets.

Q5. Who are the key aquaculture vaccine market companies?

Answer: Some of the key aquaculture vaccine companies are as follows:

• GlaxoSmithKline
• Merck
• Pfizer
• Sanofi
• CSL
• Emergent BioSolutions
• Johnson & Johnson
• AstraZeneca
• Serum Institute of India
• Bavarian Nordic

Q6. Which aquaculture vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that injected will remain the larger segment due to its widespread use in aquatic animals as a preventative measure against a number of illnesses, including as furunculosis, vibriosis, cold-water vibriosis, winter sore, IPN, and infectious salmon anemia (ISA).

Q7. In aquaculture vaccine market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to the presence of one of the region's largest aquaculture industries in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the aquaculture vaccine market by product (inactivated vaccines and DNA vaccines), route of administration (injected and oral), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Aquaculture Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Aquaculture Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Aquaculture Vaccine Market by Product
  • 3.3.1: Inactivated Vaccines
  • 3.3.2: DNA Vaccines
• 3.4: Global Aquaculture Vaccine Market by Route of Administration
  • 3.4.1: Injected
  • 3.4.2: Oral

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Aquaculture Vaccine Market by Region
• 4.2: North American Aquaculture Vaccine Market
  • 4.2.2: North American Aquaculture Vaccine Market by Route of Administration: Injected and Oral
• 4.3: European Aquaculture Vaccine Market
  • 4.3.1: European Aquaculture Vaccine Market by Product: Inactivated Vaccines and DNA Vaccines
  • 4.3.2: European Aquaculture Vaccine Market by Route of Administration: Injected and Oral
• 4.4: APAC Aquaculture Vaccine Market
  • 4.4.1: APAC Aquaculture Vaccine Market by Product: Inactivated Vaccines and DNA Vaccines
  • 4.4.2: APAC Aquaculture Vaccine Market by Route of Administration: Injected and Oral
• 4.5: ROW Aquaculture Vaccine Market
  • 4.5.1: ROW Aquaculture Vaccine Market by Product: Inactivated Vaccines and DNA Vaccines
  • 4.5.2: ROW Aquaculture Vaccine Market by Route of Administration: Injected and Oral

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Aquaculture Vaccine Market by Product
  • 6.1.2: Growth Opportunities for the Global Aquaculture Vaccine Market by Route of Administration
  • 6.1.3: Growth Opportunities for the Global Aquaculture Vaccine Market by Region
• 6.2: Emerging Trends in the Global Aquaculture Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Aquaculture Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Aquaculture Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: GlaxoSmithKline
• 7.2: Merck
• 7.3: Pfizer
• 7.4: Sanofi
• 7.5: CSL
• 7.6: Emergent BioSolutions
• 7.7: Johnson & Johnson
• 7.8: AstraZeneca
• 7.9: Serum Institute of India
• 7.10: Bavarian Nordic